[1]赵玲莉,耿惠,邓丽君,等.EPO的临床研究进展[J].青海医药杂志,2011,41(3):74-77.
[2]Scheidemann F, Therrien JP, Vogel J, et al. In vivo synthesis and secretion of erythropoietin by genetically modified primary human keratinocytes grafted onto immunocompromised mice [J].Exp Der matol, 2010, 19 (3):289-297.
[3]Haroon ZA, Amin K, Jiang X, et al. A novel role for erythropoietin during fibrin-induced wound-healing response [J].Pathol, 2003, 163(3):993-1000.
[4]Erbayraktar Z,Erbayraktar S,Yilmaz O,et al.Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing[J].Med, 2009,15(7-8):235-241.
[5]Duan W,Yang Y,Yan J,et al.The effects of curcumin post-treatment against myocardial ischemi-a and reperfusion by activation of the JAK2/STAT3 signaling pathway[J].Basic Res Cardiol,2012,107(3):1-12.
[6]王亚飞, 党晓卫,徐韶凯,等.血管生成素1/酪氨酸激酶受体2系统与门静脉高压大鼠食管壁新生血管形成的关系[J].中华实验外科杂志,2015,32(6):1333-1335.
[7]杨明忠, 陆兴安.血管生成素1在大鼠急性β射线皮肤损伤创面愈合过程中的表达[J].现代实用医学, 2011, 23(3):264-268.
[8]赵菁玲,徐盈斌,唐锦明,等.粒细胞一巨噬细胞集落刺激因子对大鼠深Ⅱ度烫伤创面血管生成素-1表达的影响[J].中华实验外科杂志,2013,30(4):697-700.
[9]吕大伦,丁伟,张炜,等.EPO 对大鼠皮肤切创愈合过程中VEGF变化影响及其与剂量、时间的相关性[J].医学美学美容杂志,2013,(7):194-195. |